The uterine natural killer cell, cytotoxic T lymphocyte, and granulysin levels are elevated in the endometrium of women with nonstructural abnormal uterine bleeding
Women with nonstructural abnormal uterine bleeding exhibit elevated endometrial levels of uterine natural killer cells, cytotoxic T lymphocytes, and granulysin, which may influence matrix metalloproteinase expression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (42)
- 60S acidic ribosomal protein P1 (RPLP1) is elevated in human endometriotic tissue and in a murine model of endometriosis and is essential for endometriotic epithelial cell survival <i>in vitro</i> via openalex
- A functional model for progestogen-induced breakthrough bleeding via openalex
- Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding? via openalex
- Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B) via openalex
- FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age via openalex
- Immunology of Normal and Abnormal Menstruation via openalex
- doi:10.1016/j.jri.2010.07.001 via openalex
- doi:10.1016/j.mce.2010.08.006 via openalex
- doi:10.1038/bjc.2012.294 via openalex
- doi:10.1093/humupd/6.1.16 via openalex
- doi:10.1093/humrep/deq020 via openalex
- doi:10.3109/14767050902994796 via openalex
- doi:10.1016/j.jri.2014.04.005 via openalex
- doi:10.1016/j.coi.2019.04.013 via openalex
- doi:10.1111/j.1471-0528.1999.tb08358.x via openalex
- doi:10.1177/1933719116682877 via openalex
- doi:10.1093/oxfordjournals.humrep.a138268 via openalex
- doi:10.4049/jimmunol.170.6.3154 via openalex
- doi:10.2174/0929867326666190730113123 via openalex
- W6828860767 via openalex
- doi:10.1016/j.pharmthera.2019.107465 via openalex
- doi:10.1038/s41467-021-22021-6 via openalex
- doi:10.1210/jc.85.10.3853 via openalex
- doi:10.1016/j.cell.2020.07.019 via openalex
- doi:10.18240/ijo.2020.07.03 via openalex
- doi:10.1093/oxfordjournals.humrep.a019416 via openalex
- doi:10.1016/j.imlet.2019.11.005 via openalex
- doi:10.4049/jimmunol.158.6.3017 via openalex
- doi:10.1093/oxfordjournals.humrep.a019474 via openalex
- doi:10.1055/s-0031-1287662 via openalex
- doi:10.1016/s0161-5890(99)00063-2 via openalex
- doi:10.2353/ajpath.2008.071169 via openalex
- doi:10.4049/jimmunol.158.6.2680 via openalex
- doi:10.1111/j.1600-0897.2011.01015.x via openalex
- doi:10.1095/biolreprod55.5.1017 via openalex
- doi:10.1093/humrep/11.suppl_2.35 via openalex
- doi:10.1007/s10529-006-9127-2 via openalex
- doi:10.1210/jc.2004-1742 via openalex
- doi:10.1111/j.1600-0897.1988.tb00208.x via openalex
- doi:10.1093/oxfordjournals.humrep.a137430 via openalex
- W148084808 via openalex
- doi:10.1093/humrep/14.3.793 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-11T05:37:28.352103+00:00